Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity

BACKGROUND AND AIMS: Despite anticoagulation, usually with heparin, mortality for thromboembolic events in COVID-19 remains high. Clinical efficacy of heparin is due to its interaction with antithrombin (AT) that may be decreased in COVID-19. Therefore, we correlated AT levels with outcomes of COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Gazzaruso, Carmine, Paolozzi, Enrico, Valenti, Cinzia, Brocchetta, Mauro, Naldani, Daniela, Grignani, Claudio, Salvucci, Fabrizio, Marino, Francesco, Coppola, Adriana, Gallotti, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386389/
https://www.ncbi.nlm.nih.gov/pubmed/32907762
http://dx.doi.org/10.1016/j.numecd.2020.07.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386389/
https://www.ncbi.nlm.nih.gov/pubmed/32907762
http://dx.doi.org/10.1016/j.numecd.2020.07.040

Ejemplares similares